FDA PMA FDA Class 3 Approved 🇺🇸 United States

Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)

PMA: P050048 · Decision Aug 25, 2006
Classifications
1
FEI Numbers
27
Registration Numbers
27

Basic Information

Device Name
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
Trade Name
MONOLISA ANTI-HBS EIA
PMA Number
P050048
Device Class
FDA Class 3
Product Code
LOM
Generic Name
Test, hepatitis b (b core, be antigen, be antibody, b core igm)
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
August 25, 2006
Date Received
December 5, 2005
Expedited Review
N
Docket Number
07M-0151

Advisory Committee Statement

APPROVAL FOR THE MONOLISA ANTI-HBS EIA AND THE MONOLISA ANTI-HBS CALIBRATOR KIT. THE DEVICES ARE INDICATED FOR: THE MONOLISA ANTI-HBS EIA IS A QUALITATIVE AND QUANTITATIVE ENZYME IMMUNOASSAY FOR THE DETECTION OF ANTIBODY TO HEPATITIS B SURFACE ANTIGEN IN HUMAN SERUM AND EDTA OR CITRATED PLASMA. THE ASSAY RESULTS MAY BE USED AS AN AID IN THE DETERMINATION OF SUSCEPTIBILITY TO HEPATITIS B VIRUS (HBV) INFECTION IN INDIVIDUALS PRIOR TO OR FOLLOWING HBV VACCINATION OR WHERE VACCINATION STATUS IS UNKNOWN. ASSAY RESULTS MAY BE USED WITH OTHER HBV SEROLOGICAL MARKERS FOR THE LABORATORY DIAGNOSIS OF HBV DISEASE ASSOCIATED WITH HBV INFECTION. A REACTIVE ASSAY RESULT WILL ALLOW A DIFFERENTIAL DIAGNOSIS IN INDIVIDUALS DISPLAYING SIGNS AND SYMPTOMS OF HEPATITIS IN WHOM ETIOLOGY IS UNKNOWN. THE MONOLISA ANTI-HBS CALIBRATOR KIT IS INTENDED FOR QUANTITATIVE DETERMINATION OF ANTI-HBS IN HUMAN SERUM AND EDTA OR CITRATED PLASMA. THE MONOLISA ANTI-HBS CALIBRATOR KIT IS TO BE USED ONLY WITH THE MONOLISA ANTI-HBS EIA.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOM Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)